Critical Care (Apr 2019)

Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial

  • Mathilde Scarton,
  • Anne Oppenheimer,
  • Khalil Chaïbi,
  • Didier Dreyfuss,
  • Stéphane Gaudry

DOI
https://doi.org/10.1186/s13054-019-2447-0
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 3

Abstract

Read online

No abstracts available.